The purpose of this Funding Opportunity Announcement (FOA)
is to encourage the submission of R01 applications from institutions in
eligible foreign countries to conduct studies in infectious disease research. Collaborations
with investigators in the United States (U.S.) are encouraged but not required.
These grants will serve to build independent research capacity by providing
direct funding to investigators who do not currently have NIH-funded grant or
contract awards for research projects. The intent of these activities is to
advance the development of local scientific expertise.
NIAID has a long-standing interest in and commitment to
global health and international research. Topics of interest for this program
are limited to research on infectious diseases, including emerging infections
that are of public health significance within the applicant country (including
but not limited to: tuberculosis; malaria; influenza; HIV/AIDS; sexually
transmitted diseases; diarrheal, respiratory, and enteric diseases; viral
hemorrhagic fevers; viral encephalitides; other viral diseases, parasitic
diseases; vector-borne diseases, and development of drug resistance).
Development of basic, immunological, microbiological, biostatistical, epidemiological,
data management, and clinical research capacity is encouraged.
Research Objectives and Scope
Studies may be proposed on any aspect of infectious disease
research (except clinical trials), including but not limited to: the
epidemiology, natural history, pathogenesis, immunopathogenesis of infectious
diseases; epidemiologic studies to define the incidence, clinical
presentations, and outcomes of diseases; identification of resistance patterns;
characterization of susceptible cohorts for a particular pathogen; pilot and
feasibility studies in preparation for larger studies. NOTE: HIV/AIDS studies
must address NIAID priorities described at http://www.niaid.nih.gov/about/whoWeAre/planningPriorities/Documents/NIAIDStrategicPlan2013.pdf
Collaborative projects involving investigators and
institutions from international sites and the U.S. are particularly encouraged;
however, a U.S. partner is not required. NIH supports a number of international
research programs on infectious diseases, including HIV/AIDS. For NIAID, these
include the International Centers of Excellence in Research (ICERs),
International Collaborations for Infectious Disease Research (ICIDRs), the
Tropical Medicine Research Centers (TMRCs), the Centers of Excellence for
Influenza Research and Surveillance (CEIRS), the International Centers of
Excellence for Malaria Research (ICEMRS), the Tuberculosis Research Unit, the
HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN),
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT),
AIDS Clinical Trials Group (ACTG), Microbicide Trials Network (MTN),
International Network for Strategic Initiatives in Global HIV Trials
(INSIGHT), the International Epidemiologic Database to Evaluate AIDS
(IeDEA), and the Centers for AIDS Research (CFAR).
This International Research in Infectious Diseases including
AIDS (IRIDA) Program (R01) is intended to extend these programs by expanding
the breadth of research supported at international sites and by providing
support to new researchers. Applications are particularly encouraged from
institutions in eligible countries where NIH has significant investments through
extramural research grants, cooperative agreements or contracts or through NIH
intramural programs. Current NIH or NIAID funding is not a requirement.
Applicants are strongly encouraged to establish
multi-institutional collaborations and to include in their research plans
activities that involve the transfer of technologies and research methods,
sharing of core resources including the administration of research grant
programs, and expansion of linkages to other sites via attendance at national
and international meetings and other methods of communication.
Eligible
- Resource-constrained Non-domestic (non-U.S.) Entities (Foreign Organizations) ONLY
- Non-domestic (non-U.S.) Entities (Foreign
Institutions) from resource-constrained countries are eligible to
apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. - Foreign components, as defined in the NIH Grants Policy Statement, are not allowed
- Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank definition). To determine the eligibility status of a country